Immediate Impact

59 standout
Sub-graph 1 of 24

Citing Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
mRNA vaccines in disease prevention and treatment
2023 Standout
2 intermediate papers

Works of Meiping Sun being referenced

Respiratory Syncytial Virus-Specific Cell-Mediated Immune Responses after Vaccination with a Purified Fusion Protein Subunit Vaccine
1994

Author Peers

Author Last Decade Papers Cites
Meiping Sun 175 26 20 117 84 35 378
Qing Xu 173 10 154 93 36 360
Lei Cao 129 10 58 60 10 50 455
W. William Schluter 183 1 3 160 46 26 412
W. C. Cockburn 162 1 93 61 27 360
H Oppermann 123 1 59 20 26 374
Laurel Edelman 300 2 1 148 49 12 456
Megan K Young 123 10 144 16 51 442
Arshad Quddus 120 1 259 247 17 451
Kwan Hong 170 1 9 79 21 34 393
Henrieta Hudečková 98 3 97 17 61 421

All Works

Loading papers...

Rankless by CCL
2026